(Q39578052)

13 September 2017

Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa (English)

1 reference

13 September 2017

1 reference

parkinsonian syndrome

1 reference

Rinne UK

1

1 reference

PubMed ID

718139

13 September 2017

Marttila R

series ordinal

2

1 reference

13 September 2017

1 September 1978

1 reference

13 September 2017

1 reference

13 September 2017

4

1 reference

13 September 2017

3

1 reference

13 September 2017

263-267

1 reference

Evidence for dopamine receptor stimulation by apomorphine.

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Parkinson Disease Treated With a Suspected Dopamine Receptor Agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

The antiparkinsonian efficacy of bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410040313

21 January 2018

Identifiers

DOI

10.1002/ANA.410040313

1 reference

13 September 2017

1 reference

PubMed ID

718139